glp-1 alcohol cravings IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target GLP-1s Hold Promise as Treatment
Description
Having ongoing support from your provider and a care team is also a plus
Patient Profiles Falsely Considered Unfit 6.2.1
GLP #2 is also FDA-approved for weight loss treatments (Zepbound and Mounjaro are some name brands)
That way, if you do experience any side effects that you are concerned about or that are too uncomfortable to handle, you can quickly get in touch with a provider for medical advice
Whether its adjusting your medication, refining your lifestyle changes, or tackling new challenges, their team is there to guide you
